NRG Transseptal Needle NRG-71-C1Recalls & reported problems
Baylis Médicale Cie Inc · Class 2
All models of NRG Transseptal Needle (8)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00685447000020), received between May 23, 2019 and May 23, 2019 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Cardiac Perforation1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMay 23, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
BAYLIS MEDICAL WAS INFORMED OF A PULMONARY VEIN ISOLATION (PVI) PROCEDURE IN WHICH THE NRG TRANSSEPTAL NEEDLE WAS USED FOR TRANSSEPTAL PUNCTURE AND A COMPLICATION OCCURRED. THE PHYSICIAN PERFORMED TWO TRANSSEPTAL PUNCTURES WITH THE NRG NEEDLE THROUGH A SL1 SHEATH WITH NO ISSUE. THE PHYSICIAN PULLED OUT THE NRG NEEDLE TO EXCHANGE FOR AN AGILIS SHEATH. NO BAYLIS PRODUCTS WERE USED AGAIN OR PLACED INSIDE THE PATIENT. THE PHYSICIAN LOST ACCESS WITH THE AGILIS SHEATH BUT WAS LATER ABLE TO CROSS AGAIN THROUGH THE SAME PUNCTURE SITE. THE CASE PROCEEDED AND LATER, A PERFORATION WAS DISCOVERED. THE PATIENT WAS DEEMED STABLE AND DID NOT HAVE TO LEAVE THE CATHETERIZATION LAB BUT THE PROCEDURE WAS ABORTED. THE NURSING STAFF INDICATED THAT THE PHYSICIAN FELT THAT THE BAYLIS NRG TRANSSEPTAL NEEDLE NRG NEEDLE WAS NOT RESPONSIBLE FOR THE PERFORATION. THE NURSING STAFF STATED THAT VERY HIGH CONTACT FORCE WAS OBSERVED ON THE MAPPING SYSTEM THROUGHOUT THE PROCEDURE. THERE IS NO EVIDENCE TO SUGGEST THAT THE BAYLIS MEDICAL DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED INCIDENT. HOWEVER, AS THE BAYLIS MEDICAL DEVICE WAS REPORTED TO BE AMONG THE DEVICES USED IN THE PROCEDURE, BAYLIS MEDICAL HAS DECIDED TO
Patient problems: Cardiac Perforation
MAUDE report 8637312 ↗
Other Catheter, Septostomy devices
- VersaCross Access Solution VXSK0031Baylis Médicale Cie Inc · Catheter, Septostomy1 recall16 reports
- VersaCross Access Solution VXSK0021Baylis Médicale Cie Inc · Catheter, Septostomy1 recall1 death15 reports
- VersaCross Access Solution VXSK0032Baylis Médicale Cie Inc · Catheter, Septostomy1 recall14 reports
- VersaCross Access Solution VXSK0022Baylis Médicale Cie Inc · Catheter, Septostomy1 recall13 reports
- VersaCross Access Solution VXSK0024Baylis Médicale Cie Inc · Catheter, Septostomy1 recall3 reports
- VersaCross Access Solution VXSK0025Baylis Médicale Cie Inc · Catheter, Septostomy1 recall1 report
- VersaCross Access Solution VXSK0034Baylis Médicale Cie Inc · Catheter, Septostomy1 recall1 report
- NRG Transseptal Needle NRG-E-HF-71-C0Boston Scientific Corporation · Catheter, Septostomy22 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page